Basic Information
| RNALocate ID: | RLID:11003366 |
| RNA Symbol: | hsa-miR-411-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-411-5p |
| RNA ID: | miRBase:MIMAT0003329 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002470 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11003365 | Exosome | Serum | 18589210 |
| RLID:11003367 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11003368 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000167 | Exosome | Blood|B lymphoblastoid cells|Endothelial cells|Mast cells | |
| RLID-D:11000542 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-411-5p | Peripheral arterial disease | MNDR-E-MI-48116 |
| MNDR | hsa-miR-411-5p | Oral squamous cell carcinoma | MNDR-E-MI-48117 |
| MNDR | hsa-miR-411-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-48118 |
| MNDR | hsa-miR-411-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-48119 |
| MNDR | hsa-miR-411-5p | Lymphoma | MNDR-E-MI-48120 |
| MNDR | hsa-miR-411-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-48121 |
| MNDR | hsa-miR-411-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-48122 |
| MNDR | hsa-miR-411-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-48123 |
| MNDR | hsa-miR-411-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-48124 |
| MNDR | hsa-miR-411-5p | Her2-receptor positive breast cancer | MNDR-E-MI-48125 |
| MNDR | hsa-miR-411-5p | Niemann-pick disease type c | MNDR-E-MI-48126 |
| MNDR | hsa-miR-411-5p | Prostate cancer | MNDR-E-MI-48127 |
| MNDR | hsa-miR-411-5p | Alzheimer disease | MNDR-E-MI-48128 |
| MNDR | hsa-miR-411-5p | Dysautonomia familial | MNDR-E-MI-48129 |
| MNDR | hsa-miR-411-5p | Head and neck cancer | MNDR-E-MI-48130 |
| MNDR | hsa-miR-411-5p | Lung cancer | MNDR-E-MI-48131 |
| MNDR | hsa-miR-411-5p | Endometrial cancer | MNDR-E-MI-48132 |
| MNDR | hsa-miR-411-5p | Down syndrome | MNDR-E-MI-48133 |
| MNDR | hsa-miR-411-5p | Parkinson disease | MNDR-E-MI-48134 |
| MNDR | hsa-miR-411-5p | Niemann-pick disease | MNDR-E-MI-48135 |
| MNDR | hsa-miR-411-5p | Breast cancer | MNDR-E-MI-48136 |
| MNDR | hsa-miR-411-5p | Thyroid cancer | MNDR-E-MI-48137 |
| MNDR | hsa-miR-411-5p | Pancreatic cancer | MNDR-E-MI-48138 |
| MNDR | hsa-miR-411-5p | Melanoma | MNDR-E-MI-48139 |
| MNDR | hsa-miR-411-5p | Nephroblastoma | MNDR-E-MI-48140 |
| MNDR | hsa-miR-411-5p | Colon cancer | MNDR-E-MI-48141 |
| MNDR | hsa-miR-411-5p | Ischemic attack transient | MNDR-E-MI-48142 |
| MNDR | hsa-miR-411-5p | Colon adenocarcinoma | MNDR-E-MI-48143 |
| MNDR | hsa-miR-411-5p | Ovarian cancer | MNDR-E-MI-48144 |
| MNDR | hsa-miR-411-5p | Prostate adenocarcinoma | MNDR-E-MI-48145 |
| MNDR | hsa-miR-411-5p | Carcinoma ductal breast | MNDR-E-MI-48146 |
| MNDR | hsa-miR-411-5p | Glioblastoma | MNDR-E-MI-48147 |
| MNDR | hsa-miR-411-5p | Astrocytoma | MNDR-E-MI-48148 |
| MNDR | hsa-miR-411-5p | Glioma | MNDR-E-MI-48149 |
| MNDR | hsa-miR-411-5p | Temporal lobe epilepsy | MNDR-E-MI-48150 |
| MNDR | hsa-miR-411-5p | Osteosarcoma | MNDR-E-MI-48151 |
| MNDR | hsa-miR-411-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-48152 |
| MNDR | hsa-miR-411-5p | Uterine cancer | MNDR-E-MI-48153 |
| MNDR | hsa-miR-411-5p | Gastric adenocarcinoma | MNDR-E-MI-48154 |
| MNDR | hsa-miR-411-5p | Cervical squamous cell carcinoma | MNDR-E-MI-48155 |
| MNDR | hsa-miR-411-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-48156 |
| MNDR | hsa-miR-411-5p | Lung adenocarcinoma | MNDR-E-MI-48157 |
| MNDR | hsa-miR-411-5p | Adrenocortical carcinoma | MNDR-E-MI-48158 |
| MNDR | hsa-miR-411-5p | Thyroid carcinoma | MNDR-E-MI-48159 |
| MNDR | hsa-miR-411-5p | Ovarian carcinoma | MNDR-E-MI-48160 |
| MNDR | hsa-miR-411-5p | Bladder urothelial carcinoma | MNDR-E-MI-48161 |
| MNDR | hsa-miR-411-5p | Pancreatic adenocarcinoma | MNDR-E-MI-48162 |
| MNDR | hsa-miR-411-5p | Carcinoma renal cell | MNDR-E-MI-48163 |
| MNDR | hsa-miR-411-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-48164 |
| MNDR | hsa-miR-411-5p | Renal clear cell carcinoma | MNDR-E-MI-48165 |
| MNDR | hsa-miR-411-5p | Synovial sarcoma | MNDR-E-MI-48166 |
| MNDR | hsa-miR-411-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-48167 |
| MNDR | hsa-miR-411-5p | Breast invasive carcinoma | MNDR-E-MI-48168 |
| MNDR | hsa-miR-411-5p | Hepatocellular carcinoma | MNDR-E-MI-48169 |
| MNDR | hsa-miR-411-5p | Rheumatoid arthritis | MNDR-E-MI-48170 |
| MNDR | hsa-miR-411-5p | Abdominal aortic aneurysm | MNDR-E-MI-48171 |
| MNDR | hsa-miR-411-5p | Osteoarthritis | MNDR-E-MI-48172 |
| MNDR | hsa-miR-411-5p | Crohn disease | MNDR-E-MI-48173 |
| MNDR | hsa-miR-411-5p | Colorectal cancer | MNDR-E-MI-48174 |
| MNDR | hsa-miR-411-5p | Esophageal squamous cell cancer | MNDR-E-MI-48175 |
| MNDR | hsa-miR-411-5p | Ependymoma | MNDR-E-MI-48176 |
| MNDR | hsa-miR-411-5p | Stroke lacunar | MNDR-E-MI-48177 |
| MNDR | hsa-miR-411-5p | Breast cancer her3+ negative | MNDR-E-MI-48178 |
| MNDR | hsa-miR-411-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-48179 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | FOXO1 | Homo sapiens | RR00576689 |
TOP